On Thursday 24 August 2017, the South African Tuberculosis Vaccine Initiative (SATVI) partnered with Ikamva Lethu, a women’s cooperative based in Worcester, in presenting a bead making workshop to learners at the Sinetemba Aftercare Centre in Zwelethemba, Worcester.
SATVI researcher Associate Professor Tom Scriba has co-authored a research paper titled: "The CSF Immune Response in HIV-1–Associated Cryptococcal Meningitis: Macrophage Activation, Correlates of Disease Severity, and Effect of Antiretroviral Therapy" appearing in the Journal of Acquired Immune Deficiency Syndrome.
South African Tuberculosis Vaccine Initiative (SATVI), located within Infectious Disease and Molecular Medicine (IDM) at the Faculty of Health Sciences invites applications from suitably qualified candidates for a 24-month contract position of Laboratory Technologist based in Worcester. CLOSED
SATVI authors have published research in which they find that the implementation of optimized procedures and a more rigorous QuantiFERON-TB conversion definition, an increase from IFNy<0.2 to >0.7 IU/mL, would allow more definitive detection of recent M.tb infection and potentially improve identification of those more likely to develop disease.